Space company Redwire trims quarterly losses, builds order backlog past $270 million
Space infrastructure company Redwire reported second-quarter results Monday, as it nearly erased its net losses.
Palantir reports 13% revenue growth, issues guidance that tops estimates
Palantir executives say revenue growth will accelerate in the third quarter, reversing a trend from the last several years.
Boeing resets Starliner plan to be ready for first NASA crew flight by March
Starliner continues to be a costly and behind-schedule endeavor for Boeing, with the company absorbing about $1.5 billion in cost overruns to date.
The Mega Millions jackpot hits $1.55 billion. What’s the best payout option? Experts weigh lump sum vs. annuity
The Mega Millions jackpot is up to $1.55 billion. Here’s how to decide between the lump sum or annuity payout option.
Red Cross ends blood-donation restrictions that singled out gay and bisexual men
The FDA in May dropped a nearly 40-year policy that had singled out men who have sex with men.
Trump counterclaim against E. Jean Carroll dismissed, DA can get deposition
E. Jean Carroll says Donald Trump raped her in the 1990s. A criminal case against the former president involving a porn star payoff is set for trial in 2024.
Zoom can now train its A.I. using some customer data, according to updated terms
Zoom’s update comes amid growing public debate on the extent to which AI services should be trained on individuals’ data.
Raymond James says this satellite stock can jump 40% and could even double
The stock could rally up to 137% in a bull case, according to Raymond James.
Sage Therapeutics stock plunges more than 50% after FDA denies wider use of postpartum depression drug
The FDA approved the pill zuranolone, developed by Sage and Biogen, for postpartum depression but declined to approve it for major depressive disorder.
